The retinal protein Nrl belongs to a distinct subfamily of basic motif-leucine zipper DNA-binding proteins and has been shown to bind extended AP-1-like sequence elements as a homo-or heterodimer. Here, we demonstrate that Nrl can positively regulate the expression of the photoreceptor cell-specific gene rhodopsin. Electrophoretic mobility-shift analysis reveals that a protein(s) in nuclear extracts from bovine retina and the Y79 human retinoblastoma cell line binds to a conserved Nrl response element (NRE) in the upstream promoter region of the rhodopsin gene. Nrl or an antigenically similar protein is shown to be part of the bound protein complex by supershift experiments using Nrl-specific antiserum. Cotransfection studies using an Nrl-expression plasmid and a luciferase reporter gene demonstrate that interaction of the Nrl protein with the -61 to -84 region of the rhodopsin promoter (which includes the NRE) stimulates expression of the reporter gene in CV-1 monkey kidney cells. This Nrl-mediated transactivation is specifically inhibited by coexpression of a naturally occurring truncated form of Nrl (dominant negative effect). Involvement of Nrl in photoreceptor gene regulation and its continued high levels of expression in the adult retina suggest that Nrl plays a significant role in controlling retinal function.
The ontogeny of retinal cell types during development has been established by anatomical and cell biological studies combined with thymidine birth-dating and lineage-tracing techniques (1) (2) (3) (4) . However, the molecular mechanisms governing the generation of photoreceptors and other neuronal cells in the mammalian retina are poorly understood. Since the induction of cell type-specific genes is involved in the commitment of multipotent precursor cells to specific neuronal lineages (5), a direct approach for dissecting the molecular events during retinal differentiation is to elucidate the mechanisms regulating differential gene expression in the retina and define the components of the transcriptional regulatory hierarchy. Identification of transcription factors and their target genes in specific retinal cell types should help to delineate the pathways of cell fate determination and may provide insights into the pathological mechanisms responsible for congenital and inherited diseases affecting retinal function.
Several transcription factor genes including homeobox (Hox), POU, paired box (Pax), and basic motif-leucine zipper (bZIP) sequences are expressed during eye development (6) (7) (8) (9) (10) (11) . However, their function in controlling developmental stage-and/or cell type-specific gene expression in the retina has not been determined. One of these potential regulatory genes, NRL (neural retina leucine zipper), cloned by a subtractive hybridization approach (11) (12) (13) , encodes a member of
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the bZIP family of DNA-binding proteins (14) . It is highly conserved between mouse and man and demonstrates a retinaspecific pattern of expression on Northern analysis (11, 13) . The Nrl protein shows strong sequence homology to the v-maf oncogene product (15) . Maf and Nrl define a distinct subfamily of bZIP proteins that includes the c-mafprotooncogene product (16) , several other Maf proteins (17, 18) , the small subunit p18 of the erythroid transcription factor NF-E2 (19) , and the product of the segmentation gene kriesler (kr) (20) . Nrl can form homodimers; it also can heterodimerize with Maf and with several members of the c-Fos and c-Jun family (21, 22 
MATERIALS AND METHODS
Nuclear Extracts and Antisera. Nuclear extracts from bovine retina, liver, and kidney were prepared as described (23, 24) . The HeLa and Y79 retinoblastoma cell nuclear extracts, as well as the c-Fos and c-Jun antibodies (TransCruz gel supershift reagent), were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The a2.3-Nrl antiserum, prepared against full-length bacterially expressed Nrl, and the corresponding preimmune serum were provided by Tom Kerppola (22) . The P1 antiserum was generated against an 11-aa synthetic peptide derived from the proline/serine/threonine (P/ S/T)-rich acidic region of Nrl (aa 23-33; .: Facility. EMSA was performed essentially as described (26) . One of the RhoP oligonucleotides was end-labeled with T4 polynucleotide kinase and [,y-32P]ATP and annealed to the complementary unlabeled oligomer. The double-stranded oligonucleotide (0.2-1 ng, 105 cpm) was incubated in binding buffer with nuclear extract (5-30 p,g) and poly(dI-dC) (50 ,tg/ml) for 30 min at room temperature. In competition experiments, unlabeled double-stranded RhoP and mRhoP oligonucleotide was used. For supershift experiments, antibody or control serum was added after the incubation of 32P-labeled RhoP with nuclear extracts. The samples were loaded on a prerun 5-8% polyacrylamide gel. After electrophoresis, the gel was dried and exposed to x-ray film for autoradiography.
Recombinant Plasmids. The human NRL (clone 321B1) and DD10 cDNAs (11) were cloned into the pMT3 vector (27) by using the EcoRI and Sal I restriction sites to generate plasmid constructs for expression in mammalian cells. The pMT-NRL plasmid expresses the wild-type Nrl protein, including a P/S/T-rich acidic region and a basic(+) motif followed by the leucine zipper domain. The pMT-DD10 plasmid encodes a truncated protein (t-Nrl) with an in-frame deletion of 105 aa (residues 23-127) including the N-terminal P/S/T-rich region. t-Nrl should be able to form homodimers, heterodimerize with the wild-type Nrl, and bind to DNA but is predicted to lack the transactivation function. The pMT-NRLAZ plasmid was derived from pMT-NRL by deleting the sequence (bp 761-812 in the NRL cDNA; ref. 11) encoding part of the leucine zipper domain. Therefore, the resultant mutant protein lacks the dimerization and DNA-binding function of wild-type Nrl. Luciferase reporter constructs were generated from the pGL2-Basic vector (Promega, Madison, WI) by cloning various upstream regions of the rhodopsin gene (28) . The p61-Luc, p84-Luc, p130-Luc, p176-Luc, and p225-Luc constructs contain sequences derived from the bovine rhodopsin gene extending from -61 to +72, -84 to +72, -130 to +72, -176 to +72, and -225 to +72 bp, respectively. The p4907-Luc construct contains mouse rhodopsin gene sequence extending from bp -4907 to bp +85.
Transfection Experiments. All transfections for the analysis of transcriptional activity of the wild-type and variant Nrl proteins were performed in CV-1 monkey kidney cells by the DEAE-dextran method (29) and included the pCMV-3-galactosidase expression plasmid as an internal control to normalize for variations in transfection efficiency. The activity of luciferase and ,B-galactosidase was measured in cell extracts, prepared 60 hr posttransfection, by the methods provided with the respective kits (Promega).
Analysis of Nrl Proteins Expressed in Transfected Cells. Expression of Nrl and its variant proteins from the pMT constructs was analyzed by published methods (29 mM NaCl/0.5% Triton X-100/0.5% sodium deoxycholate/ 0.02% sodium azide) at 4°C for 15-30 min. The nuclear fraction was removed by centrifugation, and the supernatant was incubated overnight at 4°C with control preimmune serum or Nrl-specific antiserum (a2.3 or P1). The immunocomplex was isolated by incubation with protein A-Sepharose (Pharmacia). After washing in RIPA buffer, the samples were boiled in Laemmli buffer and analyzed by SDS/PAGE (10% or 14%) followed by fluorography.
RESULTS
Retinal Nuclear Extract Contains a Protein(s) That Interacts with the Rhodopsin NRE. Previous studies identified both proximal and distal regulatory regions upstream of the bovine and mouse rhodopsin genes (24, 25, 28, 30, 31) . The proximal regulatory region at bp -225 to +72 in the bovine gene is sufficient to direct photoreceptor cell-specific expression of a reporter gene in transgenic mice, whereas the distal regulatory region (located -2 kb upstream) functions as an enhancer. The proximal upstream region contains several potential sites for DNA-binding proteins (28, (32) (33) (34) , including an NRE-like sequence [bp -66 to -54 in the human sequence (35) ; Fig.  1A] , which has been shown to bind to Escherichia coliexpressed Nrl (36) . This putative NRE in the proximal regulatory region is highly conserved in the human, bovine, and mouse rhodopsin genes (Fig. 1A) . EMSA of a 24-bp oligonucleotide, RhoP (Fig. 1A) , corresponding to the human sequence containing the putative NRE, demonstrated specific shifts in mobility (indicated by * and **) upon incubation with bovine retinal nuclear extract (Fig. 1B, lane 5) . The intensity of the shifted bands decreased with addition of increasing 192 Genetics: Rehemtulla et al.
amounts of unlabeled RhoP oligonucleotide (lanes 4-2), but no significant competition was observed even with a 500-fold molar excess of a mutant oligomer (mRhoP) containing five nucleotide substitutions in the NRE (lane 1). EMSA using the labeled mRhoP oligonucleotide detected no significant mobility shift with the retinal nuclear extract (data not shown). Nuclear extract from the human Y79 retinoblastoma cell line (which expresses the NRL gene; ref. 11) showed mobility shifts with wild-type RhoP that were similar to those observed with the bovine retinal nuclear extract (Fig. IB, lane 10) . Unlabeled RhoP (lanes 9-7) , but not mRhoP (lane 6), competed efficiently with the RhoP probe for formation of the shifted bands (* and ** in Fig. IB) . Nuclear extracts from cells and tissues that do not express NRL, such as HeLa cells, liver, and kidney (refs. 11 and 13; A.S., unpublished data), did not show evidence of specific gel shifts (data not shown).
NrI Is Part of the Protein Complex That Binds to the Rhodopsin NRE. Addition of Nrl-specific antiserum a2.3 after incubation of RhoP with the retinal (Fig. 2, lane 3) or Y79 (lane 8) nuclear extract showed a mobility supershift (**) with a concomitant disappearance of the previously shifted complex (*). However, the addition of preimmune serum (lanes 4 and 9) did not supershift the RhoP complex. These results suggest that Nrl or an antigenically similar protein in the retinal and Y79 nuclear extracts is part of the protein complex that binds to the RhoP oligonucleotide. No significant supershift was observed with the antibodies against c-Jun (lanes 1 and 6) and c-Fos (lanes 2 and 7) under the present conditions, despite the ability of c-Jun and c-Fos to heterodimerize with Nrl (22) .
Coexpression of Nrl Transactivates the Rhodopsin Promoter. To test the ability of Nrl to regulate rhodopsin gene expression in a heterologous cell culture system, we constructed three Nrl expression plasmids (Fig. 3A) . pMT-NRL expressed in COS-1 cells yielded two major Nrl immunoreactive polypeptides of 43 and 35 kDa (Fig. 3B, lane 2) , which were absent in the immunoprecipitate of mock-transfected cell (Fig. 3B, lane 3) . pMT-DD10, containing a previously identified truncated cDNA (DD1O; ref. 11), produced polypeptides of 17 and 16 kDa (Fig. 3B, lane 4) . The discrepancy between the predicted (31 kDa for the wild-type Nrl) and observed molecular masses of expressed Nrl protein appears to be due to differential posttranslational modification, as confirmed by metabolic labeling experiments in COS cells (A.R. and A.S., unpublished data). Western analysis of bovine and human retinal proteins detected similar high molecular weight polypeptides with affinity-purified Nrlspecific antibodies (X.J. & A.S., unpublished data). The size difference between the wild-type and variant proteins is in agreement with differences in their primary sequence.
To directly test the ability of Nrl to regulate rhodopsin expression, pMT-NRL was cotransfected into CV-1 cells with reporter constructs containing various fragments of the rhodopsin promoter. Cotransfection of pMT-NRL with the p84-Luc construct, which contains a complete NRE, consistently led to 3-fold stimulation of luciferase activity (Fig. 4) . p61-Luc, which does not contain a complete NRE, showed no induction upon Nrl expression. p130-Luc and p176-Luc also showed responsiveness to Nrl, whereas p225-Luc and p4907-Luc were unresponsive to Nrl-mediated transactivation. Deletion of 41 bp in the multiple cloning site of the vector in p176-Luc (called pA176-Luc), which altered the junction region upstream of the promoter sequence, did not have any significant effect on Nrl-mediated transactivation (data not shown).
Truncated Nrl Inhibits Nrl-Mediated Transactivation. To examine the specificity of Nrl-mediated transactivation, pMT-NRLAZ and pMT-DD10, encoding variant Nrl proteins (see above and Fig. 3 ), were tested in cotransfection experiments. These two plasmids had no effect on luciferase expression from the p84-Luc construct (Fig. 5) . pMT-NRLAvZ, when -4907, -225, -176, -130, -84 , and -61, respectively) constructs were transfected into CV-1 cells in the presence or absence of pMT-NRL. Cell extracts were assayed for luciferase and f-galactosidase activity. Data shown represent luciferase activity from three independent transfections (error bars represent 1 SD) and have been normalized using 13-galactosidase activity that is driven by the cytomegalovirus promoter and hence not affected by Nrl expression. Vertical dashed line, background luminescence in the absence of added cell extract. Transactivation with p84-Luc and p130-Luc is statistically significant at P c 0.0005, and that with p176-Luc, at P 0.0015. cotransfected along with pMT-NRL, had no significant effect on the p84-Luc expression induced by Nrl; however, pMT-DD1O consistently inhibited Nrl-mediated transactivation of rhodopsin promoter activity (Fig. 5) .
DISCUSSION
Several members of the Maf-Nrl subfamily of bZIP proteins have been identified and implicated in the regulation of cell type-specific gene expression (11, 13, (15) (16) (17) (18) (19) (20) . p18 and several small Maf proteins can dimerize with the p45 subunit of the NF-E2 transcription factor and regulate erythroid-specific gene expression (19, 37, 38) . c-Maf can stimulate transcription from a Purkinje neuron-specific promoter (16) . The kreisler (kr) gene appears to be involved in hindbrain and otic development (20) . Here, we report that the Nrl protein, which binds to an extended AP-1 element, participates in regulating the photoreceptor cell-specific gene rhodopsin.
Our studies directly implicate Nrl in mammalian photoreceptor cell-specific gene regulation. The presence of binding sites for several DNA-binding proteins in the upstream rhodopsin promoter region (28, (32) (33) (34) suggests that a combinatorial and synergistic interaction of multiple transcription factors (5, 39) is probably responsible for achieving stringently controlled cell type-and developmental stage-specific expression of the rhodopsin gene. We demonstrate by EMSA that a conserved NRE-like sequence in the proximal regulatory region of the rhodopsin promoter binds to Nrl (or an antigenically similar protein) present in the bovine retinal nuclear extract. Our results, however, do not reveal the nature of additional proteins that may be part of the protein complex bound to the rhodopsin NRE. The lack of supershift of RhoP complexes (obtained with either the retinal or Y79 extracts) by c-Jun or c-Fos antiserum suggests that the c-Jun and c-Fos proteins may not play a significant role in NRE-mediated regulation of rhodopsin expression.
Cotransfection studies in CV-1 cells, which do not express rhodopsin or NRL, show that the wild-type Nrl protein can interact with sequences in the rhodopsin promoter constructs p84-Luc, p130-Luc, and p176-Luc and transactivate expression of the reporter gene. The lack of Nrl-mediated transactivation of p61-Luc is consistent with Nrl acting through NRE, which is present in p84-Luc but not in p61-Luc. Since the expression of rhodopsin is highly restricted in a cell type-and developmental stage-specific manner, one would predict that negative regulatory elements play a role in maintaining this high degree of specificity. The finding of decreased activity and responsiveness of p176-Luc and virtually no transactivation of p225-Luc does not prove but is consistent with this hypothesis. We speculate that repression of rhodopsin promoter function in CV-1 cells may be mediated by a negative regulatory factor that binds to sequences in the -225 promoter. Involvement of additional trans-acting factors (both positive and negative) in rhodopsin regulation in vivo is expected since Nrl 
